Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.

Neurobiology of Disease
Wenzhen DuanC A Ross

Abstract

Huntington's disease (HD) is an inherited progressive neurodegenerative disorder resulting from CAG repeat expansion in the gene that encodes for the protein huntingtin. To identify neuroprotective compound (s) that can slow down disease progression and can be administered long term with few side effects in Huntington's disease, we investigated the effect of sertraline, a selective serotonin reuptake inhibitor (SSRI) which has been shown to upregulate BDNF levels in rodent brains. We report here that in HD mice sertraline increased BDNF levels, preserved chaperone protein HSP70 and Bcl-2 levels in brains, attenuated the progression of brain atrophy and behavioral abnormalities and thereby increased survival. Sertraline also enhanced neurogenesis, which appeared to be responsible for mediating the beneficial effects of sertraline in HD mice. Additionally, the effective levels of sertraline are comparable to the safe levels achievable in humans. The findings suggest that sertraline is a potential candidate for treatment of HD patients.

References

Jun 28, 2002·Trends in Neurosciences·Carl W Cotman, Nicole C Berchtold
Aug 6, 2002·Nature Medicine·Michelle L MonjeTheo D Palmer
Feb 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Wenzhen DuanMark P Mattson
Apr 25, 2003·Trends in Genetics : TIG·Katharine L Sugars, David C Rubinsztein
Sep 10, 2003·CNS Drugs·Anne E Rosser, Stephen B Dunnett
Mar 6, 2004·Neuromolecular Medicine·Ronald S Duman
Mar 30, 2004·Annals of Neurology·Wenzhen DuanMark P Mattson
Apr 10, 2004·Neuroreport·Stanley E LazicRoger A Barker
Apr 27, 2004·Nature·Christoph Schmidt-HieberJosef Bischofberger
May 4, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adrian P KellsBronwen Connor
Jul 24, 2004·Nature Medicine·Christopher A Ross, Michelle A Poirier
Mar 31, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ming ZhaoSharyn D Baker
Sep 17, 2005·Nature Reviews. Molecular Cell Biology·Christopher A Ross, Michelle A Poirier
Oct 26, 2005·Trends in Pharmacological Sciences·Jessica E Malberg, Julie A Blendy
Jun 16, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Toru YamashitaKazunobu Sawamoto
Sep 27, 2006·Neuroreport·Wendy PhillipsRoger A Barker
Oct 5, 2006·Current Topics in Medicinal Chemistry·Ejner K Moltzen, Benny Bang-Andersen
Apr 19, 2007·Clinical and Experimental Pharmacology & Physiology·Maurice A CurtisRichard L M Faull
May 3, 2007·Physics in Medicine and Biology·Hua DengJohn Wong

❮ Previous
Next ❯

Citations

Feb 9, 2012·Current Treatment Options in Neurology·Annie Killoran, Kevin M Biglan
Sep 5, 2012·Molecular Neurobiology·Pawel M SwitonskiMaciej Figiel
Oct 17, 2013·Archives of Pharmacal Research·Hyun-Jung KimSun-Young Kong
Jul 3, 2010·International Psychogeriatrics·Robert C Baldwin
Aug 21, 2013·Cell Death & Disease·J SassoneA Ciammola
Feb 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ryan L BoudreauBeverly L Davidson
Jul 29, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chi-Tso ChiuDe-Maw Chuang
Jun 6, 2009·Nature Reviews. Neurology·Chiara Zuccato, Elena Cattaneo
Jul 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Malini VashishthaLeslie M Thompson
Sep 21, 2010·Antioxidants & Redox Signaling·Sarah J Texel, Mark P Mattson
Nov 26, 2010·Human Molecular Genetics·Mohamed R MughalMark P Mattson
May 15, 2013·Human Molecular Genetics·Fengli WangTie-Shan Tang
Jan 10, 2013·Pharmacological Reviews·Chi-Tso ChiuDe-Maw Chuang
Feb 17, 2009·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Theo Hagg
Apr 13, 2011·PloS One·Fanny MochelRaphael Schiffmann
Oct 23, 2013·PloS One·Jianfang ChenJonathan H Fox
Nov 20, 2013·International Journal of Molecular Sciences·Edward C Lauterbach
Jan 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Christopher W NgErnest Fraenkel
Aug 16, 2014·Zeitschrift für medizinische Physik·Falk TillnerWolfgang Enghardt
Nov 29, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Danielle A SimmonsFrank M Longo
Mar 9, 2012·Psychiatry Research·Kelly C RoweUNKNOWN PREDICT-HD Investigators of the Huntington Study Group
Oct 14, 2014·BioMed Research International·Jonasz Jeremiasz WeberJeannette Hübener
May 6, 2014·Frontiers in Behavioral Neuroscience·Patrick PlaSandrine Humbert
Jul 18, 2008·Handbook of Clinical Neurology·Jean Paul G VonsattelMaria Del Pilar Amaya
Jun 7, 2011·Journal of Chemical Neuroanatomy·Serena BovettiAldo Fasolo
Nov 22, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Puneet Kumar, Anil Kumar
Jan 12, 2013·Dementia and Geriatric Cognitive Disorders·Brian S ApplebyJeffrey L Cummings
Dec 20, 2017·Journal of Huntington's Disease·Danielle A Simmons
Jun 13, 2018·The Journal of Biological Chemistry·Yanchun PanHiroko Yano
Aug 5, 2009·Journal of Neurochemistry·Peter O Bauer, Nobuyuki Nukina
Jul 2, 2011·British Journal of Pharmacology·Thibault RenoirAnthony J Hannan
Sep 6, 2014·Expert Review of Neurotherapeutics·Masahisa KatsunoGen Sobue
Jul 29, 2010·Physiological Reviews·Chiara ZuccatoElena Cattaneo
Oct 9, 2019·Journal of Huntington's Disease·Rachel Y CheongÅsa Petersén

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.